Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 02, 2022
Sterling Pharma Solutions has reached an agreement with Novartis to acquire its Ringaskiddy campus (Novartis Ringaskiddy Limited), near Cork, Ireland. Financial details of the sale, which is expected to close in Q4, 2022, have not been disclosed.
read more
Sterling Pharma Solutions, a global contract development and manufacturing organization, announced a $3 million investment at its Germantown, WI facility, to expand its integrated antibody-drug conjugate (ADC) development and manufacturing ...
read more
Wednesday, January 24, 2018
API developer and manufacturer, Sterling Pharma Solutions, announced it is expanding its capacity in Japan.
read more
Tuesday, October 08, 2024
Sterling Pharma Solutions, a contract development and manufacturing organization, and Soligenix, a late-stage biopharmaceutical company focused on developing and commercialization of products to treat rare diseases where there is an unmet medical ...
read more
Hovione today announced that its API plant in Cork, Ireland has successfully passed a pre-approval inspection by the US Food and Drug Administration (FDA).
read more
Thursday, December 18, 2014
Hovione today announced that the U.S. Food and Drug Administration (FDA) performed a Pre-Approval Inspection to its plant in Loures, Portugal, covering two NDA filings. At the conclusion of the inspection, the FDA issued a Form 483 with three ...
read more
Wednesday, February 26, 2020
Sun Pharmaceutical has launched Riomet ER™ in the U.S. to improve glycemic control in patients 10 years of age and older with type 2 diabetes mellitus.
read more
Wednesday, December 30, 2020
SAI is voluntarily recalling Paroex Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 12/31/2020 – 9/30/2022 to the consumer level.
read more
Ginkgo Bioworks and Swissaustral announced a new partnership to design strains of microorganisms that will produce industrial enzymes at scale.
read more
Sygnature Discovery announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. The new service line expands the company’s portfolio into formal preclinical drug development. A new world-class facility with ...
read more
Takeda has officially opened a new manufacturing plant at its site at Grange Castle, in Dublin, Ireland.
read more
Ovid announced the closing of the Royalty, License and Termination agreement under which Takeda secured global rights from Ovid to develop and commercialize soticlestat.
read more
Monday, February 24, 2020
Taro is voluntarily recalling two lots of Phenytoin Oral Suspension USP, 125 mg/5 mL both in 237 mL bottles, to the consumer level.
read more
Tuesday, January 14, 2020
Tauriga Sciences announced plans to commence development of a pharmaceutical grade version of Tauri-Gum.
read more
Tetra has awarded the contract for the manufacturing of its API, HU-308, and of the intravenous, sterile, finished drug product ARDS-003 to Dalton.
read more